Tags

Type your tag names separated by a space and hit enter

Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients.
Infect Disord Drug Targets. 2020; 20(4):407-408.ID

Authors+Show Affiliations

Department of Geriatric Medicine and Memory Clinic, Research Center on Autonomy and Longevity, University Hospital, Angers, France.State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072, China.State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072, China.EFFE, 252 Bd Grignan, 83000 Toulon, France.EFFE, 252 Bd Grignan, 83000 Toulon, France.Universite Aix-Marseille, Institut de Neuro-physiopathologie (INP), UMR 7051, Faculte de Pharmacie, 27 Bd Jean Moulin, 13385 Marseille Cedex, France.Universite Aix-Marseille, Institut de Neuro-physiopathologie (INP), UMR 7051, Faculte de Pharmacie, 27 Bd Jean Moulin, 13385 Marseille Cedex, France.

Pub Type(s)

Editorial

Language

eng

PubMed ID

32418532

Citation

Annweiler, Cédric, et al. "Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients." Infectious Disorders Drug Targets, vol. 20, no. 4, 2020, pp. 407-408.
Annweiler C, Cao Z, Wu Y, et al. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets. 2020;20(4):407-408.
Annweiler, C., Cao, Z., Wu, Y., Faucon, E., Mouhat, S., Kovacic, H., & Sabatier, J. M. (2020). Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infectious Disorders Drug Targets, 20(4), 407-408. https://doi.org/10.2174/1871526520666200518073329
Annweiler C, et al. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets. 2020;20(4):407-408. PubMed PMID: 32418532.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. AU - Annweiler,Cédric, AU - Cao,Zhijian, AU - Wu,Yingliang, AU - Faucon,Emmanuelle, AU - Mouhat,Stéphanie, AU - Kovacic,Hervé, AU - Sabatier,Jean-Marc, PY - 2020/5/19/pubmed PY - 2020/5/19/medline PY - 2020/5/19/entrez SP - 407 EP - 408 JF - Infectious disorders drug targets JO - Infect Disord Drug Targets VL - 20 IS - 4 SN - 2212-3989 UR - https://www.unboundmedicine.com/medline/citation/32418532/Counter_regulatory_'Renin_Angiotensin'_System_based_Candidate_Drugs_to_Treat_COVID_19_Diseases_in_SARS_CoV_2_infected_patients_ L2 - https://www.eurekaselect.com/182054/article DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.